Literature DB >> 27400984

Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement From the American Heart Association.

Robert L Page, Cindy L O'Bryant, Davy Cheng, Tristan J Dow, Bonnie Ky, C Michael Stein, Anne P Spencer, Robin J Trupp, JoAnn Lindenfeld.   

Abstract

Heart failure is a common, costly, and debilitating syndrome that is associated with a highly complex drug regimen, a large number of comorbidities, and a large and often disparate number of healthcare providers. All of these factors conspire to increase the risk of heart failure exacerbation by direct myocardial toxicity, drug-drug interactions, or both. This scientific statement is designed to serve as a comprehensive and accessible source of drugs that may cause or exacerbate heart failure to assist healthcare providers in improving the quality of care for these patients.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  AHA Scientific Statements; drug interactions; drug monitoring; drug therapy; drug-related adverse effects and adverse reactions; heart failure; nonprescription drugs

Mesh:

Substances:

Year:  2016        PMID: 27400984     DOI: 10.1161/CIR.0000000000000426

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  97 in total

Review 1.  SGLT2 inhibition and heart failure-current concepts.

Authors:  Joaquim Silva Custodio; Andre Rodrigues Duraes; Marconi Abreu; Natalia Albuquerque Rocha; Leonardo Roever
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

2.  Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults.

Authors:  Alex Secora; G Caleb Alexander; Shoshana H Ballew; Josef Coresh; Morgan E Grams
Journal:  Drugs Aging       Date:  2018-08       Impact factor: 3.923

3.  Guideline-led prescribing to ambulatory heart failure patients in a cardiology outpatient service.

Authors:  Seif El Hadidi; Carl Vaughan; David Kerins; Stephen Byrne; Ebtissam Darweesh; Margaret Bermingham
Journal:  Int J Clin Pharm       Date:  2021-01-07

Review 4.  Toxicity testing is evolving!

Authors:  Ida Fischer; Catherine Milton; Heather Wallace
Journal:  Toxicol Res (Camb)       Date:  2020-04-24       Impact factor: 3.524

Review 5.  Chronic heart failure.

Authors:  Ingrid Hopper; Kellie Easton
Journal:  Aust Prescr       Date:  2017-08-01

Review 6.  Hospice in heart failure: why, when, and what then?

Authors:  Jeffrey L Spiess
Journal:  Heart Fail Rev       Date:  2017-09       Impact factor: 4.214

7.  Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity.

Authors:  Dylan J Richards; Yang Li; Charles M Kerr; Jenny Yao; Gyda C Beeson; Robert C Coyle; Xun Chen; Jia Jia; Brooke Damon; Robert Wilson; E Starr Hazard; Gary Hardiman; Donald R Menick; Craig C Beeson; Hai Yao; Tong Ye; Ying Mei
Journal:  Nat Biomed Eng       Date:  2020-04-13       Impact factor: 25.671

Review 8.  Cardiac Rehabilitation to Optimize Medication Regimens in Heart Failure.

Authors:  Parag Goyal; Eiran Z Gorodeski; Zachary A Marcum; Daniel E Forman
Journal:  Clin Geriatr Med       Date:  2019-06-21       Impact factor: 3.076

Review 9.  Genetic Aspects and Immune Responses in Covid-19: Important Organ Involvement.

Authors:  Zari Naderi Ghale-Noie; Arash Salmaninejad; Robert Bergquist; Samaneh Mollazadeh; Benyamin Hoseini; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Current drug therapy for heart failure with reduced ejection fraction.

Authors:  D Berliner; M Hallbaum; J Bauersachs
Journal:  Herz       Date:  2018-08       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.